Pandameds.Com Editorial Team
The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.
Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.
Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers
Recent Blog Post
Zepbound Diarrhea: 23% Rate + Management Timeline
Zepbound diarrhea affects approximately 23% of users at the maximum 15mg dose, according to data from the SURMOUNT clinical trials. This gastrointestinal side effect typically begins 2-3 days after your injection and peaks around week 5 during dose escalation. Diarrhea is the second most common GI side effect after nausea when taking this weight management [...]
How Zepbound Works: Dual GLP-1/GIP Action – Appetite Off Week 1
Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72. This dual hormone action is superior to single GLP-1 drugs like Wegovy and Ozempic. According to the FDA approval announcement, Zepbound (tirzepatide) represents a breakthrough in [...]
Zepbound Dose Schedule: 2.5mg Start → 15mg Max + Maintenance Guide
The Zepbound dose schedule follows FDA-approved titration starting at 2.5mg once weekly, increasing every 4 weeks to reach the maximum recommended dosage of 15mg. According to FDA prescribing information, this slow titration approach reduces gastrointestinal adverse reactions while allowing your body to adjust to this injectable prescription medicine. In clinical trials like SURMOUNT-1, adults taking [...]
Zepbound Injection Sites: Abdomen, Thigh, Arm + Needle Size Guide
The Zepbound auto-injector delivers precise doses ranging from 2.5mg to 15mg in approximately 10 seconds. According to the FDA prescribing information, the approved injection sites for Zepbound are the stomach (maintaining at least 2 inches from the navel), outer thigh, and back of the upper arm. The Zepbound pen comes with a pre-attached 32-gauge, 4mm [...]
Zepbound Side Effects: Nausea, GI Symptoms & Muscle Pain Timeline Guide
Zepbound side effects impact approximately 82% of users during the first month of treatment, with nausea (up to 29%), diarrhea (up to 23%), constipation (up to 17%), and vomiting (up to 13%) being the most frequently reported according to FDA prescribing information. These gastrointestinal symptoms typically peak during weeks 4-8 when patients are titrating to [...]
Mounjaro Nausea: 12-24% Rate Peaks Week 4 – 90% Resolve Management Guide
Mounjaro (tirzepatide) is an FDA-approved medication that helps manage blood glucose levels in adults with Type 2 diabetes and is also highly effective for weight loss. While this weight loss injection has shown remarkable results in clinical trials, helping people lose weight significantly, nausea from Mounjaro remains the most common side effect that patients experience [...]
Mounjaro Face: Facial Fat Loss from Rapid Weight Loss – Prevention Guide
Mounjaro face describes the gaunt, hollow facial appearance that develops when tirzepatide therapy causes rapid facial fat loss. This phenomenon affects approximately 15-25% of women over 40 using weight loss medications and results from the body losing subcutaneous fat from the cheeks, temples, and under-eye areas faster than the skin can adapt. According to the [...]
Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery
Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and managing blood sugar levels. While taking Mounjaro, many patients report feeling tired-particularly during the initial [...]
Zepbound vs Wegovy: 20% vs 14% Weight Loss – Head-to-Head Trial
Zepbound beats Wegovy with 20.2% vs 13.7% body weight loss in the first-ever head-to-head trial (SURMOUNT-5), published in the New England Journal of Medicine. The key difference: Zepbound is a dual GLP-1 and GIP receptor agonist, while Wegovy targets only GLP-1. Both are FDA-approved injectable weight loss medications that require weekly injections alongside healthy eating [...]
How Much Weight Can You Lose on Wegovy? 15-17% Average + Timeline Chart
The average weight loss on Wegovy is 15% of body weight (approximately 35 pounds) after 68 weeks of treatment with the 2.4mg maintenance dose, according to clinical trial data published in the New England Journal of Medicine. This once-weekly injection, containing the active ingredient semaglutide, works by mimicking a natural hormone called GLP-1 that signals [...]
